Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
Go back to Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes| Edwards Lifesciences (NYSE: EW) | Delayed: 86.17 -2.61 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.78 | 52 Week High | $166.87 | |||
| Open | $88.70 | 52 Week Low | $72.20 | |||
| Day High | $88.79 | P/E | 25.05 | |||
| Day Low | $86.08 | EPS | $3.44 | |||
| Volume | 1,907,628 | |||||
